BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 33022499)

  • 1. An inadvertent issue of human retina exposure to endocrine disrupting chemicals: A safety assessment.
    Li M; Yang T; Gao L; Xu H
    Chemosphere; 2021 Feb; 264(Pt 1):128484. PubMed ID: 33022499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta Disrupted: Endocrine Disrupting Chemicals and Pregnancy.
    Gingrich J; Ticiani E; Veiga-Lopez A
    Trends Endocrinol Metab; 2020 Jul; 31(7):508-524. PubMed ID: 32249015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
    Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
    Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
    Ottinger MA; Abdelnabi MA; Henry P; McGary S; Thompson N; Wu JM
    Horm Behav; 2001 Sep; 40(2):234-47. PubMed ID: 11534988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle.
    Dickerson SM; Gore AC
    Rev Endocr Metab Disord; 2007 Jun; 8(2):143-59. PubMed ID: 17674209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
    Yilmaz B; Terekeci H; Sandal S; Kelestimur F
    Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of endocrine-disrupting chemicals on placental development.
    Yan Y; Guo F; Liu K; Ding R; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1059854. PubMed ID: 36896182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
    Smith CJ; Perfetti TA; Hayes AW; Berry SC
    Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral concentration and toxicity of endocrine disrupting chemicals: The implication of blood-brain interfaces.
    Denuzière A; Ghersi-Egea JF
    Neurotoxicology; 2022 Jul; 91():100-118. PubMed ID: 35436567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
    Gore AC; Chappell VA; Fenton SE; Flaws JA; Nadal A; Prins GS; Toppari J; Zoeller RT
    Endocr Rev; 2015 Dec; 36(6):E1-E150. PubMed ID: 26544531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of endocrine-disrupting chemicals on neural development and the onset of neurological disorders.
    Kajta M; Wójtowicz AK
    Pharmacol Rep; 2013; 65(6):1632-9. PubMed ID: 24553011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine Disrupting Chemicals' Effects in Children: What We Know and What We Need to Learn?
    Predieri B; Iughetti L; Bernasconi S; Street ME
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers.
    Rutkowska AZ; Szybiak A; Serkies K; Rachoń D
    Pol Arch Med Wewn; 2016 Aug; 126(7-8):562-70. PubMed ID: 27509913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endocrine disrupting chemicals in pigs.
    Yang C; Song G; Lim W
    Environ Pollut; 2020 Aug; 263(Pt B):114505. PubMed ID: 32268228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine-Disrupting Chemicals: Introduction to the Theme.
    Lisco G; Giagulli VA; Iovino M; Guastamacchia E; Pergola G; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):677-685. PubMed ID: 33847259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine-Disrupting Chemicals and Disease Endpoints.
    Ahn C; Jeung EB
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
    Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
    Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.